Posted in | News

Patent Infringement Case Involving Lightweight Rooftop Mounting Products

SunPower Corp. (Nasdaq: SPWRA, SPWRB) and SunLink Corporation today announced the two companies have settled a patent infringement case brought by SunPower before the U.S. District Court for the Northern District of California.

SunPower brought the lawsuit against SunLink in February 2008 asserting infringement of SunPower's patent rights covering its lightweight rooftop mounting products, SunPower® PowerGuard® and the SunPower® T10 Solar Roof Tile.

Under the terms of the settlement agreement, the specifics of which are confidential, SunLink has acknowledged the infringement of SunLink's MMS rooftop solar product as well as the validity and enforceability of SunPower's patent rights. For confidential consideration provided under the settlement, SunLink has received a license to SunPower's infringed patents.

"SunPower has a long history of developing industry-leading technology and we will take actions necessary to protect and enforce our intellectual property rights," said SunPower CEO Tom Werner. "We are glad to achieve a resolution to this lawsuit consistent with this objective."

"We are happy to bring this litigation to a close with an agreement that is not only beneficial to both parties, but also protects our current and future customers," said SunLink CEO Christopher Tilley. "With these licenses, we continue to add to SunLink's IP portfolio and are looking forward to introducing new, innovative photovoltaic mounting solutions to the market soon."

SunPower holds more than 120 patents for its innovative solar technology, including the world's most efficient solar cell and the recently launched SunPower® T5 Solar Roof Tile.

Source: http://us.sunpowercorp.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.